362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation

Jayal Desai; S-W Han; M.D. Forster; T.W. Kim; G. Casal; E. Shmueli; S.E. Bowyer; M.J. Miguel; A. Gonzalez; Robert Jones; Matthew Krebs; W.H. Miller; L. Paz-Ares; Patricia Lorusso; A. Sacher; N. Dharia; M.T. Lin; J.L. Schutzman; Z. Shi; M. Patel

doi:10.1016/j.annonc.2022.07.500

362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation

Jayal Desai, S-W Han, M.D. Forster, T.W. Kim, G. Casal, E. Shmueli, S.E. Bowyer, M.J. Miguel, A. Gonzalez, Robert Jones, Matthew Krebs, W.H. Miller, L. Paz-Ares, Patricia Lorusso, A. Sacher, N. Dharia, M.T. Lin, J.L. Schutzman, Z. Shi, M. Patel

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S701-S702
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.07.500
Publication status	Published - 1 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2022.07.500

Cite this

Desai, J., Han, S.-W., Forster, M. D., Kim, T. W., Casal, G., Shmueli, E., Bowyer, S. E., Miguel, M. J., Gonzalez, A., Jones, R., Krebs, M., Miller, W. H., Paz-Ares, L., Lorusso, P., Sacher, A., Dharia, N., Lin, M. T., Schutzman, J. L., Shi, Z., & Patel, M. (2022). 362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation. Annals of Oncology, 33, S701-S702. https://doi.org/10.1016/j.annonc.2022.07.500

@article{459df35f9bd7484daaa3e1b1be3bbd73,

title = "362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation",

author = "Jayal Desai and S-W Han and M.D. Forster and T.W. Kim and G. Casal and E. Shmueli and S.E. Bowyer and M.J. Miguel and A. Gonzalez and Robert Jones and Matthew Krebs and W.H. Miller and L. Paz-Ares and Patricia Lorusso and A. Sacher and N. Dharia and M.T. Lin and J.L. Schutzman and Z. Shi and M. Patel",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.annonc.2022.07.500",

language = "English",

volume = "33",

pages = "S701--S702",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

}

Desai, J, Han, S-W, Forster, MD, Kim, TW, Casal, G, Shmueli, E, Bowyer, SE, Miguel, MJ, Gonzalez, A, Jones, R, Krebs, M, Miller, WH, Paz-Ares, L, Lorusso, P, Sacher, A, Dharia, N, Lin, MT, Schutzman, JL, Shi, Z & Patel, M 2022, '362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation', Annals of Oncology, vol. 33, pp. S701-S702. https://doi.org/10.1016/j.annonc.2022.07.500

TY - JOUR

T1 - 362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation

AU - Desai, Jayal

AU - Han, S-W

AU - Forster, M.D.

AU - Kim, T.W.

AU - Casal, G.

AU - Shmueli, E.

AU - Bowyer, S.E.

AU - Miguel, M.J.

AU - Gonzalez, A.

AU - Jones, Robert

AU - Krebs, Matthew

AU - Miller, W.H.

AU - Paz-Ares, L.

AU - Lorusso, Patricia

AU - Sacher, A.

AU - Dharia, N.

AU - Lin, M.T.

AU - Schutzman, J.L.

AU - Shi, Z.

AU - Patel, M.

PY - 2022/9/1

Y1 - 2022/9/1

U2 - 10.1016/j.annonc.2022.07.500

DO - 10.1016/j.annonc.2022.07.500

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S701-S702

JO - Annals of Oncology

JF - Annals of Oncology

ER -